AAAAAA

   
Results: 1-9 |
Results: 9
Humoral mechanisms in prostate cancer: A role for FSH
Authors: Porter, AT Ben-Josef, E
Citation: At. Porter et E. Ben-josef, Humoral mechanisms in prostate cancer: A role for FSH, UROL ONCOL, 6(4), 2001, pp. 131-138
Neoadjuvant estramustine and etoposide followed by concurrent estramustineand definitive radiotherapy for locally advanced prostate cancer: Feasibility and preliminary results
Authors: Ben-Josef, E Porter, AT Han, S Mertens, W Chuba, P Fontana, J Hussain, M
Citation: E. Ben-josef et al., Neoadjuvant estramustine and etoposide followed by concurrent estramustineand definitive radiotherapy for locally advanced prostate cancer: Feasibility and preliminary results, INT J RAD O, 49(3), 2001, pp. 699-703
Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters
Authors: Merati, K Siadaty, MS Andea, A Sarkar, F Ben-Josef, E Mohammad, R Philip, P Shields, AF Vaitkevicius, V Grignon, DJ Adsay, NV
Citation: K. Merati et al., Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters, AM J CL ONC, 24(5), 2001, pp. 447-452
External beam radiotherapy for painful osseous metastases: Pooled data dose response analysis
Authors: Ben-Josef, E Shamsa, F Youssef, E Porter, AT
Citation: E. Ben-josef et al., External beam radiotherapy for painful osseous metastases: Pooled data dose response analysis, INT J RAD O, 45(3), 1999, pp. 715-719
Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis
Authors: Garde, SV Basrur, VS Li, L Finkelman, MA Krishan, A Wellham, L Ben-Josef, E Haddad, M Taylor, JD Porter, AT Tang, DG
Citation: Sv. Garde et al., Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis, PROSTATE, 38(2), 1999, pp. 118-125
Mass energy-absorption coefficients and mass collision stopping powers forelectrons in tumors of various histologies
Authors: Maughan, RL Chuba, P Porter, AT Ben-Josef, E Lucas, DR Bjarngard, BE
Citation: Rl. Maughan et al., Mass energy-absorption coefficients and mass collision stopping powers forelectrons in tumors of various histologies, MED PHYS, 26(3), 1999, pp. 472-477
Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR)
Authors: Ben-Josef, E Yang, SY Ji, TH Bidart, JM Garde, SV Chopra, DP Porter, AT Tang, DG
Citation: E. Ben-josef et al., Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR), J UROL, 161(3), 1999, pp. 970-976
Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chain
Authors: Joshi, B Li, L Taffe, BG Zhu, ZY Wahl, S Tian, H Ben-Josef, E Taylor, JD Porter, AT Tang, DG
Citation: B. Joshi et al., Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chain, CANCER RES, 59(17), 1999, pp. 4343-4355
Comment on: A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish head and neck cancer study (DAHNCA)protocol 5-85
Authors: Ben-Josef, E
Citation: E. Ben-josef, Comment on: A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish head and neck cancer study (DAHNCA)protocol 5-85, RADIOTH ONC, 48(3), 1998, pp. 344-345
Risultati: 1-9 |